MI SB0552

Requires health insurers that cover prescription drugs to provide coverage for non-opioid medications prescribed for pain treatment or management

Mandates insurers add FDA-approved non-opioid pain drugs to their preferred drug list or formulary within 90 days of the drug becoming available for retail sale

Prohibits insurers from disadvantaging non-opioid pain medications compared to opioid analgesics, including designating non-opioids as non-preferred when opioids are preferred

Bars insurers from imposing more restrictive prior authorization or step therapy requirements on non-opioid pain drugs than the least restrictive controls applied to opioid medications

Allows insurers to prefer one opioid over another opioid, or one non-opioid pain drug over another non-opioid, when establishing formularies